USE IN SPECIFIC POPULATIONS
Innovative approaches in designing a pregabalin orodispersible film for epilepsy treatment.
8.7 Hepatic Impairment
An updated overview of the emerging role of patch and film-based buccal delivery systems. An insight into preparatory methods and characterization of orodispersible film—a review. Orodispersible films–recent developments and new applications in drug delivery and therapy. Jannini EA, Droupy S. Needs and expectations of patients with erectile dysfunction: an update on pharmacological innovations in phosphodiesterase type 5 inhibition with focus on sildenafil.
Viagra Tablets
Oral films: current status and future perspectives: I—galenical development and quality attributes. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements. Orodispersible thin film: a new patient-centered innovation. Özakar RS, Özakar E. Current overview of oral thin films.
8.7 Hepatic Impairment
Thin films as an emerging platform for drug delivery. Orally disintegrating films: a modern expansion in drug delivery system. Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations. Orally disintegrating systems: innovations in formulation and technology. Advances in orodispersible films for drug delivery. Orodispersible films containing ball milled aripiprazole-poloxamer(R)407 solid dispersions. Thakkar S, Misra M. Electrospun polymeric nanofibers: new horizons in drug delivery.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 50mg | 20 Pills | 40.52€ 38.59€ | |
| Viagra Generic | 100mg | 180 + 8 Pills | 199.37€ 189.88€ | |
| Viagra Generic | 150mg | 270 + 10 Pills | 326.61€ 311.06€ | |
| Kamagra | 100mg | 60 + 4 Pills | 201.34€ 191.75€ | |
| Viagra Generic | 200mg | 120 + 8 Pills | 204.80€ 195.05€ | |
| Kamagra Polo | 100mg | 84 + 4 Pills | 244.49€ 232.85€ | |
| Viagra Generic | 100mg | 270 + 10 Pills | 270.47€ 257.59€ | |
| Viagra Generic | 50mg | 120 + 6 Pills | 129.64€ 123.47€ | |
| Viagra Generic | 100mg | 60 + 4 Pills | 96.36€ 91.77€ | |
| Kamagra Soft Tabs | 100mg | 272 + 12 Pills | 593.42€ 565.16€ |
Incorporation of lysozyme into a mucoadhesive electrospun patch for rapid protein delivery to the oral mucosa. Electrospinning of pullulan-based orodispersible films containing sildenafil.
- These tablets provide a discreet alternative to traditional pills.
- They are designed to dissolve quickly in the mouth or be swallowed.
- Suitable for people who have difficulty swallowing capsules.
Recent progress in orodispersible films‐mediated therapeutic applications: a review. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective. Drug-printing by flexographic printing technology—a new manufacturing process for orodispersible films. Preis M, Breitkreutz sildenafil syrup J, Sandler N. Perspective: concepts of printing technologies for oral film formulations. The application of 3D printing in the formulation of multilayered fast dissolving oral films.
| Population Group | Frequency |
|---|---|
| Adults with ED | Once per day as needed |
| Patients with PAH | As prescribed by physician |
| Special considerations | Avoid exceeding prescribed dosage |
Fused deposition modeling (FDM), the new asset for the production of tailored medicines. 3D printing: innovative solutions for patients and pharmaceutical industry. 3D printing technologies: recent development and emerging applications in various drug delivery systems.
5.1 Hypotension
Orodispersible tablets: a comprehensive review. A novel approach for drug delivery system in orodispersible tablet. A comprehensive review of patented technologies to fabricate orodispersible films: proof of patent analysis (2000–2020). Shanmugam S. Granulation techniques and technologies: recent progresses.
2.2 DosageModificationsforDrug Interactions
Kumar AK, Nayyar P, Kumar S. Fast dissolving tablets-A review. Aarti J, Sonali J, Ganesh D. Orodispersible tablets: a comprehensive review. Seager H.
Does sildenafil interact with foods or drinks?
Drug-delivery products and the zydis fast-dissolving dosage form. A review on mouth dissolving tablet techniques. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Puttalingaiah L, Kavitha K, Mani T. Fast disintegrating tablets: an overview of formulation, technology and evaluation. Woertz C, Kleinebudde P. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide. Characterization of hydrophilic polymers as a syringe extrusion 3D printing material for orodispersible film. Semi-solid extrusion 3D printing ODFs: an individual drug delivery system for small scale pharmacy. Bioequivalence study of a new sildenafil 100 mg orodispersible film compared to the conventional film-coated 100 mg tablet administered to healthy male volunteers. Pharmacokinetic comparison of an orally disintegrating film formulation with a film-coated tablet formulation of sildenafil in healthy Korean subjects: a randomized, open-label, single-dose, 2-period crossover study. Bioequivalence and bioavailability of an Orodispersible tablet of sildenafil citrate in healthy Chinese male subjects. Bioequivalence studies of sildenafil citrate orodispersible film administered with and without water versus Viagra® film-coated tablets in healthy male subjects. EDEUS, a real-life study on the users of phosphodiesterase type 5 inhibitors: prevalence, perceptions, and health care-seeking behavior among European men with a focus on 2nd-generation avanafil. Health-related characteristics and unmet needs of men with erectile dysfunction: a survey in five European countries. Andersson K-E. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Anatomy, physiology, and pathophysiology of erectile dysfunction.
7.3 Amlodipine
Orodispersible films—pharmaceutical development for improved performance: a review. Orodispersible film, a new concept in drug delivery technology. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate. Designing orodispersible films containing everolimus for enhanced compliance and bioavailability. Patel P, Prajapati B, Patel D. The Italian society of Andrology and sexual medicine (SIAMS), along with ten other Italian scientific societies, guidelines on the diagnosis and management of erectile dysfunction. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction: pharmacology and clinical impact of the sildenafil citrate orodispersible tablet formulation. Subclinical erectile dysfunction: proposal sildenafil oral jelly 100 mg for a novel taxonomic category in sexual medicine. Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Erectile dysfunction and cardiovascular risk: a review of current findings. SM= SM: the interface of systems medicine and sexual medicine for facing non-communicable diseases in a gender-dependent manner. Insights into modifiable risk factors of erectile dysfunction, a wide-angled mendelian randomization study. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies.
- Sildenafil film tablets are often used for pulmonary arterial hypertension off-label.
- They work by relaxing blood vessels to improve blood flow.
- Medical guidance is essential for off-label or long-term use.
Comment on “association between cardiometabolic index and erectile dysfunction among US adults: a cross-sectional analysis of the national health and nutrition examination survey 2001–2004”.
| Storage Condition | Details |
|---|---|
| Temperature | Store below 30°C |
| Humidity | Keep in dry place |
| Light Exposure | Protect from direct light |
| Packaging | Keep in original container |
Type 5 phosphodiesterase (PDE5) and the vascular tree: from embryogenesis to aging and disease. Evaluation and management of erectile dysfunction in clinical practice. Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic, and efficacy profiles.
| Brand Name | Manufacturer | Packaging |
|---|---|---|
| Viagra | Pfizer | Blister pack |
| Revatio | Pfizer | Bottle |
| Sildenafil Citrate | Various generic manufacturers | Varies |
Evans JD, Hill SR. A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Viagra 50 mg film-coated tablets - summary of product characteristics (SmPC) - (emc). [ updated 2023 May 4; cited 2024 Mar 6]. The first‐generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue. Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects. Clinical analysis on the pharmaceutical formulation of VIAGRA OD film. First‐generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta‐analysis. Bioerodable film for delivery of pharmaceutical compounds of mucosal surfaces. United States patent US 6,159,498. Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Patel P, Prajapati BG, Patel D. Mouth dissolving film as a potential dosage form for paediatric usage. Wasilewska K, Winnicka K. How to assess orodispersible film quality?
8. Use In Specific Populations
Orally disintegrating tablets: formulation, preparation techniques and evaluation. Formulation and quality control of orally disintegrating tablets (ODTs): recent advances and perspectives. Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. An overview on mouth dissolving tablet: from manufacturing and patented technique to quality control test.
Sildenafil Oral Film for ED
Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review. Method for sildenafil from canada producing a rapidly dissolving dosage form. United States patent US 6,066,337. Formulation and evaluation of mouth dissolving tablet. Oral dispersible system: a new approach in drug delivery system.
Adverse Reactions/Side Effects
Recent trends of fast dissolving tablet-an overview of formulation technology. Recent trends of fast dissolving drug delivery system-an overview of formulation technology. Comoglu T, Dilek Ozyilmaz E. Orally disintegrating tablets and orally disintegrating mini tablets–novel dosage forms for pediatric use. Arora P, Sethi VA. A review of applied methods and their modifications.
How to use Daktarin Gold 2% Cream
Formulation evaluation of mouth dissolving tablets of fenofibrate using sublimation technique. Present investigations and future prospects of oral disintegrating tablets: a review. Mouth dissolving tablets: an overview on future compaction in oral formulation technologies. Nayak AK, Manna K. Current developments in orally disintegrating tablet technology.
What should I do if I miss a dose of sildenafil?
Chauhan K, Solanki R, Sharma S. A review on fast dissolving tablet. Orodispersible films: current innovations and emerging trends. Gijare C, Deshpande A. Orodispersible films: a systematic patent review. Sildenafil is commonly used for the following conditions. Erectile dysfunction, a condition where you have trouble getting or keeping an erection Pulmonary arterial hypertension, a condition where you have high blood pressure in the blood vessels that carry blood from your heart to your lungs Sildenafil may also be used for other conditions as determined by your healthcare provider.